Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blueberries MedicalBBRRF Receivables Turnover is 0.65 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 949 Drug Manufacturers companies, Blueberries Medical ranks worse than 75.03% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Blueberries Medical's Revenue for the
three
months ended in Mar. 2026 was $0.03 Mil. Blueberries Medical's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.05 Mil.
Hence, Blueberries Medical's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.65.
Blueberries Medical (OTCPK:BBRRF) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Blueberries Medical Receivables Turnover Related Terms
Blueberries Medical Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Blueberries Medical's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BBRRF vs ZTS, UTHR: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blueberries Medical (BBRRF) has a Receivables Turnover of 0.65 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Blueberries Medical and its competitors. According to the industry distribution chart, Blueberries Medical ranks #712 out of 949 companies in the Drug Manufacturers industry, placing it in the top 75%.
Is Blueberries Medical's Receivables Turnover too high?
Blueberries Medical's current Receivables Turnover is 0.65. The Drug Manufacturers industry median Receivables Turnover is 5.07. Blueberries Medical's value of 0.65 is 87.2% below this industry median. Based on the distribution chart, Blueberries Medical ranks #712 out of 949 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Blueberries Medical's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #712 out of 949 companies for Receivables Turnover. This places Blueberries Medical in the lower half of its industry. The industry median Receivables Turnover is 5.07. Blueberries Medical's value of 0.65 is 87.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 949 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueberries Medical's current Receivables Turnover of 0.65 is 87.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current Receivables Turnover is 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current Receivables Turnover of 0.65. The current Receivables Turnover is 0.65 and 87.2% below the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current Receivables Turnover is 0.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 
